L.S. v. Happy Hippo, LLC

Summary

The United States District Court for the Eastern District of California grants plaintiff L.S.’s motion to proceed under a pseudonym in a putative class action concerning alleged nondisclosure of kratom’s addictive nature. The court also grants in part the defendant’s motion to dismiss, addressing judicial notice, incorporation by reference, and claims under California’s False Advertising Law, Unfair Competition Law, and Consumers Legal Remedies Act. The document text provided does not include the complete disposition of all claims or the opinion’s date.

Holdings

1. Plaintiff may proceed under a pseudonym at this stage because the sensitive and personal nature of the allegations, the reasonable risk of social stigma, the absence of demonstrated prejudice to defendant, and the limited public interest in disclosure outweigh the presumption of public identification.
2. A claim under California's FAL, UCL, or CLRA may be based on a pure omission when the omitted fact is one the defendant had a duty to disclose.
3. Plaintiff plausibly alleged that defendant had an affirmative duty to disclose kratom's addictive nature because he alleged an unreasonable safety hazard and facts supporting defendant's superior or exclusive knowledge.
4. Plaintiff adequately pleaded reliance by alleging that he would not have purchased the products had the packaging disclosed their addictive properties.
5. The breach of implied warranty claim must be dismissed because plaintiff alleged that he purchased the products from a smoke shop and did not allege vertical privity with defendant.
6. The unjust enrichment and fraudulent omission claims were adequately pleaded and were not dismissed.

Questions Presented

1. Whether plaintiff should be permitted to proceed under a pseudonym because the action involves sensitive allegations concerning drug addiction.
2. Whether California's False Advertising Law, Unfair Competition Law, and Consumers Legal Remedies Act permit claims based on a pure omission where the defendant allegedly had a duty to disclose.
3. Whether plaintiff plausibly alleged an affirmative duty to disclose kratom's addictive nature based on an unreasonable safety hazard and defendant's superior or exclusive knowledge.
4. Whether plaintiff adequately alleged reliance on the alleged omission.
5. Whether plaintiff's breach of implied warranty claim was barred by lack of vertical privity.
6. Whether plaintiff adequately stated unjust enrichment and fraudulent-omission claims.

Disposition

other